Mesothelioma

Typically, however, it can take a few decades before someone sees the effects.

"That's why (asbestos) is so insidious," Merchant said.

"You go in there, you work, you breathe in the dust and figure, no problem.

Years later, you get sick." Merchant said the violation was more "egregious" than most because Advertisementof the size of the building, the number of employees involved and the scope of the job.

Clifford Cheng, a principal with Cheng, Chow and Chu, bought the 52,000-square-foot facility on behalf of his firm in 1993.

According to court records, he received an asbestos survey identifying the locations of the fibrous mineral when he bought the property.

He was unable to be reached for comment Monday.

Five attached buildings occupy the property bounded by Main Street, Maple Court and A Street.

It began as Levine Hospital, a 16-bed eye, ear, nose and throat clinic and surgical hospitalin the early 1950s.

It expanded over the years and developers built an eight-story extension in the early 1970s.

It later became a campus for Life Chiropractic College and now is home to various businesses, including Everest College, and several clinics and medical offices.

It was not until the later 1970s and 1980s that industries began phasing out the use of asbestos.

The U.S.

banned most asbestos-containing materials in 1989.

The Bay Area Air ...

Shares were up 7% after Study Results Demonstrating Potential of Alfacell's ONCONASE.

BellwetherReport.com is a leading online research firm for international investors looking to get an edge over their portfolio.

Investors seeking the most up to date information on Alfacell Corp are invited to sign up for a free complimentary subscription to www.bellwetherreport.com.

No credit card needed!

Alfacell Corporation announced that in vivo study results demonstrating the potential of ONCONASE (ranpirnase) for the treatment of non-small cell lung cancer (NSCLC) were recently published in Anticancer Research (2007; 27: 299- 308).

Based on the work of Intae Lee, Ph.D., at the University of Pennsylvania, a paper entitled "Antitumor Efficacy of the Cytotoxic RNase, Ranpirnase, on A549 Human Lung Cancer Xenografts of Nude Mice" shows that: * ONCONASE significantly inhibited tumor growth of A549 NSCLC cells both in vitro and in vivo; apoptosis was significantly induced by ONCONASE in a dose-dependent manner * Multiple small doses of ONCONASE were more effective than one large single dose of ONCONASE for the inhibition of tumor growth in animal studies * ONCONASE in combination with cisplatin significantly reduced tumor growth of A549 cells; in large tumors, including those unsuccessfully t...

of Malvern, PA; CISBIO is the exclusive distributor of MESOMARK in Europe, where it is currently undergoing evaluation for clinical use.

The MESOMARK test is now accessible to physicians across the U.S.

for monitoring patients who have been diagnosed with epithelioid or biphasic This minimally-invasive tool requires only a blood sample.

The transition of the MESOMARK test from research to clinical usage will be significant in managing An estimated 10.000 new cases are diagnosed in industrialized countries each year.

Although recent progress has been made in chemotherapy and surgical techniques for treatment, diagnosing and monitoring remain difficult.

Current testing methods used to determine patient treatment can be invasive and costly.

The MESOMARK Assay is a manual enzyme-linked immunosorbent assay (ELISA) that identifies a group of molecular markers called soluble mesothelin-related proteins (SMRP).

Released into the bloodstream by The approval was given under the FDA’s Humanitarian Device Exemption (HDE) program, which authorizes companies to market medical devices to treat or diagnose diseases which meet certa...